AzTrials
AzTrials

EndometriosisENDOPSYNCT07280052

Psychological Support Interventions for Women With Endometriosis (ENDOPSY)

A study testing Individual Psychotherapy, Socio-Aesthetic Group Therapy and Mixed Psychotherapy in people with Endometriosis, run by Hospices Civils de Lyon at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Endometriosis is associated with severe pain, impaired quality of life and significant psychological distress. Psychological support may help improve emotional regulation, mental health, and quality of life in affected women. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Endometriosis
What is being tested?
Individual Psychotherapy, Socio-Aesthetic Group Therapy and Mixed Psychotherapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteFrance
Study dates
Feb 2026to Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult women ≥18 years
  • Clinical diagnosis of endometriosis
  • Ability to understand and complete psychological evaluations
  • Signed written informed consent

Who cannot join

  • Ongoing psychotherapy
  • Cognitive, sensory or language impairments preventing participation
  • Participation in another interventional clinical study
  • Persons under legal protection
  • Non-French speakers
  • Pregnancy or breastfeeding

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site
  • Hôpital Lyon Sud - Hospices Civils de Lyon

    Pierre-Bénite, 69310

    Mariane Lecointe, 04 78 86 66 53 ext. +33, mariane.lecointe@chu-lyon.fr

    François GOLFIER, Pr

Other trials in France

About this study

Official title: Psychological Support Interventions and Their Effect on Quality of Life and Psychological Functioning in Women With Endometriosis: A Randomized Controlled Trial (ENDOPSY)

Endometriosis is associated with severe pain, impaired quality of life and significant psychological distress. Psychological support may help improve emotional regulation, mental health, and quality of life in affected women. This randomized controlled trial evaluates the impact of three psychological support interventions-individual psychotherapy, socio-aesthetic group therapy, and a mixed approach combining both-on psychological symptoms and quality of life. Forty participants will be randomized into four parallel arms. The study hypothesis is that psychological support interventions improve psychological functioning and disease-related quality of life compared with no intervention, and that the combined mixed approach may produce greater benefits than the individual or group interventions alone.

Conditions
Endometriosis
Being tested
Individual Psychotherapy, Socio-Aesthetic Group Therapy, Mixed Psychotherapy
Keywords
Endometriosis, Psychological Support, Psychotherapy, Quality of Life, Anxiety, Depression, Emotional Regulation, Women's Health
Medical subject headings
Endometriosis, Anxiety Disorders, Depression, Emotional Regulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Individual PsychotherapyBehavioural

    Ten individual psychotherapy sessions (45 minutes each) delivered every two weeks for 5 months by trained psychologists.

  • Socio-Aesthetic Group TherapyBehavioural

    Six socio-aesthetic therapy workshops (2 hours each) every two weeks over 3 months, focusing on body image, sensory experience, and emotional expression.

  • Mixed PsychotherapyBehavioural

    Combined individual and group psychotherapy including alternating sessions and final integrative sessions matching the number and duration of individual and group interventions.

Study groups in NCT07280052
Study groupRoleWhat they receive
CONTROL Group - No Psychological InterventionNo interventionParticipants receive no structured psychological intervention during the 5-month study period. Usual medical care continues without modification.
INDIVIDUAL PSYCHOTHERAPY - Individual Psychotherapy (PI)OtherIndividual psychotherapy sessions conducted by trained clinical psychologists. Ten sessions lasting 45 minutes each are delivered every two weeks over a 5-month period. The intervention focuses on emotional experience, psychological support, and associative processes related to endometriosis.
Receives: Behavioral: Individual Psychotherapy
SOCIO-AESTHETIC GROUP THERAPY - Socio-Aesthetic Group Therapy (PG)OtherSix socio-aesthetic group therapy workshops delivered every two weeks over approximately three months. Sessions last 2 hours each and include skincare, sensory exploration, self-image work, and shared emotional expression. Co-conducted by a socio-esthetician and a psychologist.
Receives: Behavioral: Mixed Psychotherapy
MIXED PSYCHOTHERAPY - Mixed Individual + Group Psychotherapy (PGI)OtherCombined intervention including two initial individual sessions, alternating individual and group therapy thereafter, and three closing individual sessions. Duration and number of sessions match the individual and group-only interventions.
Receives: Behavioral: Socio-Aesthetic Group Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Endometriosis-Related Quality of Life (EHP-30 score)

    Change in the EHP-30 total score between baseline and post-intervention. Higher scores indicate worse quality of life.

    Measured: Baseline (T1) and 5 months (T2)

Secondary outcomes (5)
  1. Change in Anxiety Symptoms (HADS-A score)

    Change in anxiety symptoms measured by the Hospital Anxiety and Depression Scale - Anxiety subscale (HADS-A) between baseline and T2.

    The HADS-A consists of 7 items scored from 0 to 3, with a total score ranging from 0 to 21.

    Higher scores indicate more severe anxiety symptoms.

    Measured: Baseline and 5 months

  2. Change in Depression Symptoms (HADS-D score)

    Change in depressive symptoms measured by the Hospital Anxiety and Depression Scale - Depression subscale (HADS-D) between baseline and T2.

    The HADS-D consists of 7 items scored from 0 to 3, with a total score ranging from 0 to 21.

    Higher scores indicate more severe depressive symptoms.

    Measured: Baseline and 5 months

  3. Change in Alexithymia (TAS-20 score)

    Change in alexithymia measured by the Toronto Alexithymia Scale - 20 items (TAS-20) between baseline and T2.

    The TAS-20 consists of 20 items scored from 1 to 5, with a total score ranging from 20 to 100.

    Higher scores indicate higher levels of alexithymia.

    Measured: Baseline and 5 months

  4. Change in Emotion Regulation (ERQ scores)

    Change in emotion regulation measured by the Emotion Regulation Questionnaire (ERQ) cognitive reappraisal and expressive suppression subscales between baseline and T2.

    The ERQ includes two subscales:

    Cognitive Reappraisal (6 items; score range 6 to 42)

    Expressive Suppression (4 items; score range 4 to 28)

    Items are scored on a 7-point Likert scale. Higher scores indicate greater use of the corresponding emotion regulation strategy.

    Measured: Baseline and 5 months

  5. Qualitative Themes Emerging From Semi-Structured Interviews

    Qualitative analysis of thematic content from baseline and final interviews.

    Measured: Baseline and 5 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Dec 2025
  2. Study startFeb 2026 (estimated)
  3. Primary completionJun 2027 (estimated)
  4. Study completionJun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Four-arm parallel randomized study evaluating three psychological interventions versus control.
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07280052
Sponsor's protocol ID
69HCL25_0655
Other IDs
2025-A02054-45
Acronym
ENDOPSY
Status last verified
Jan 2026
First submitted
1 Dec 2025
Last updated
29 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: De-identified individual participant data (IPD) will not be made publicly available or shared with external researchers. This study collects sensitive psychological and health-related data in a small, single-center cohort. Even after de-identification/pseudonymization, the risk of re-identification cannot be sufficiently minimized. Study results may be shared in aggregate form (e.g., summary statistics) in publications and presentations.

Questions about this trial

What is this clinical trial studying?

A study testing Individual Psychotherapy, Socio-Aesthetic Group Therapy and Mixed Psychotherapy in people with Endometriosis, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 29 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Lecointe Mariane (04 78 86 66 53 ext. +33, mariane.lecointe@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Endometriosis-Related Quality of Life (EHP-30 score) (time frame: Baseline (T1) and 5 months (T2)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in